Korro Bio, Inc. (KRRO)
12.17
+0.55
(+4.73%)
USD |
NASDAQ |
Sep 04, 12:26
Korro Bio Total Assets (Quarterly) : 163.45M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 163.45M |
| March 31, 2026 | 183.62M |
| December 31, 2025 | 115.71M |
| September 30, 2025 | 161.55M |
| June 30, 2025 | 180.42M |
| March 31, 2025 | 202.21M |
| December 31, 2024 | 226.24M |
| September 30, 2024 | 243.54M |
| June 30, 2024 | 249.59M |
| March 31, 2024 | 197.98M |
| December 31, 2023 | 221.66M |
| September 30, 2023 | 46.35M |
| June 30, 2023 | 79.38M |
| March 31, 2023 | 101.50M |
| Date | Value |
|---|---|
| December 31, 2022 | 73.74M |
| September 30, 2022 | 136.01M |
| June 30, 2022 | 149.66M |
| March 31, 2022 | 164.94M |
| December 31, 2021 | 185.36M |
| September 30, 2021 | 202.18M |
| June 30, 2021 | 220.21M |
| March 31, 2021 | 241.51M |
| December 31, 2020 | 264.72M |
| September 30, 2020 | 234.32M |
| June 30, 2020 | 204.79M |
| March 31, 2020 | 215.72M |
| December 31, 2019 | 223.22M |
| September 30, 2019 | 170.85M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 60.22M |
| Shareholders Equity (Quarterly) | 103.23M |
| Debt to Equity Ratio | 0.4089 |
| Current Ratio | 9.553 |
| Net Debt Paydown Yield | 0.31% |